Stem Cell Therapy Market: Growth Factors, Analytical Overview and Forecast To 2025

A stem cell therapy market forecast report has projected that orthopedic segment is estimated to observe more than 9% growth rate over 2019-2025. The growth of orthopedic stem cell industry share can be accredited to increase in number of trauma and accidents cases across the globe. Stem cell therapy has successfully found its application in treatment of bone-joint injuries which include fractured bone and spinal defects, femoral head, osteogenesis imperfecta, and ligament tendon.

As per the Centers for Disease Control and Prevention (CDC), heart diseases in the U.S. cause nearly 655,000 deaths each year. The development of novel therapies will aid in treating patients suffering from cardiovascular disease more effectively and reducing mortality rates. Ongoing examination of the different aspects of stem cell therapy by researchers to explore its application in neurological disorders can help in the treatment of complex diseases.

Request for a sample copy of this report @

A substantial upsurge in the worldwide geriatric population is likely to push the growth graph of stem cell therapy market size in ensuing years. Aged people are more vulnerable to degenerative disorders such as Alzheimer’s and Parkinson’s diseases. Stem cell therapies provide numerous advantages over the conventional therapeutic methods which makes it apt to be preferred for treating degenerative diseases. Newly advanced stem cell therapies produce healthy cells by substituting defective cells via minimally invasive techniques. Thus, a major percentage of the geriatric populace depends on stem cell therapies which has proven to be advantageous for stem cell therapy industry outlook.

In 2018, clinics segment accounted for almost 35% revenue share and helped to propel stem cell therapy industry outlook. Clinics are well equipped with skilled professionals and innovative medical equipment which allow them to offer high-class stem cell therapies. Clinics can offer specialized stem cell treatment in areas like oncology, orthopedics, and cardiovascular which is beneficial for development of stem cell therapy industry trends from clinics segment.

In 2018, stem cell therapy market from allogenic stem cell therapy segment garnered about $3 billion and is expected to grow considerably in the times to come. Allogenic transplant entirely substitutes host cells with donor cells. It also possesses capabilities to remove genetic alterations and viral reservoirs. For that reason, allogenic stem cell therapies are being highly used to offer treatment to patients dealing with leukemia and numerous other life-threatening diseases. Such numerous benefits provided by allogenic stem cell therapy are likely to upsurge its demand, thereby proliferating segmental and stem cell therapy industry size growth.

Europe’s stem cell therapy market is projected to experience a CAGR of nearly 10% up to 2025. The escalating prevalence of various chronic diseases will drive the demand for advanced therapeutic solutions in the region. Ongoing efforts from regulatory bodies to create awareness regarding stem cell therapy and its advantages among people will bolster the regional industry outlook.

There are several prominent market players partaking in stem cell therapy market share including Cellectis, Astellas Pharma, Celyad, Gamida Cell, ReNeuron Group, Capricor Therapeutics, Novadip Biosciences, Cellular Dynamics, CESCA Therapeutics, OxStem, Mesoblast, Takeda Pharmaceuticals, and DiscGenics.

Request for customization @

Partial Chapter of the Table of Content

Chapter 4.    Stem Cell Therapy Market, By Type

4.1. Key segment trends

4.2. Allogenic stem cell therapy

4.2.1.  Market size, by region, 2014-2025 (USD Million)

4.3. Autologous stem cell therapy

4.3.1.  Market size, by region, 2014-2025 (USD Million)

Chapter 5.    Stem Cell Therapy Market, By Application

5.1. Key segment trends

5.2. Oncology

5.2.1.  Market size, by region, 2014-2025 (USD Million)

5.3. Orthopedic

5.3.1.  Market size, by region, 2014-2025 (USD Million)

5.4. Cardiovascular

5.4.1.  Market size, by region, 2014-2025 (USD Million)

5.5. Neurology

5.5.1.  Market size, by region, 2014-2025 (USD Million)

5.6. Others

5.6.1.  Market size, by region, 2014-2025 (USD Million)

Chapter 6. Stem Cell Therapy Market, By End-users

6.1. Key segment trends

6.2. Hospitals

6.2.1.  Market size, by region, 2014-2025 (USD Million)

6.3. Clinics

6.3.1.  Market size, by region, 2014-2025 (USD Million)

6.4. Others

6.4.1.  Market size, by region, 2014-2025 (USD Million)

Browse full table of contents (TOC) of this report @